Injection site reactions Injection site reactions represent the second major category of adverse events with cagrilintide, and this is where the compound differs most dramatically from GLP-1 medications
The most often and potent ones attracted are the insulin receptor substrates 1/2 (IRS1/2)although there are 6 found to date- (not to forget that Shc proteins, p60dok, Cbl, APS, and Gab-1 are also recruited to activated IRs)
Pharmacists engaged in compounding are expected to follow applicable standards and regulations for the types of preparations that are compounded
Other factors may also impact differences such as age, source of mice, animal facility temperature, diet, and the microbiome which have demonstrated impacts on both obesity and cancer 29
Used needles are considered medical waste and should never be thrown into the regular trash or recycling bin